HSBC/CALL/CENTENE/100/0.1/16.01.26 Stock

Warrant

DE000HS5RQ08

Real-time Bid/Ask 13:13:02 2024-06-03 EDT
0.39 EUR / 0.41 EUR +17.65% Intraday chart for HSBC/CALL/CENTENE/100/0.1/16.01.26
1 month-33.33%
Date Price Change
24-06-03 0.39 +14.71%
24-05-31 0.34 +9.68%
24-05-30 0.31 -26.19%
24-05-29 0.42 -14.29%
24-05-28 0.49 0.00%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 02:32 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CENTENE CORPORATION
Issuer HSBC
WKN HS5RQ0
ISINDE000HS5RQ08
Date issued 2024-03-28
Strike 100 $
Maturity 2026-01-16 (592 Days)
Parity 10 : 1
Emission price 0.69
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.68
Lowest since issue 0.31
Delta0.31x
Omega 4.927
Premium47.48x
Gearing15.87x
Moneyness 0.7083
Difference Strike 29.36 $
Difference Strike %+29.36%
Spread 0.02
Spread %4.76%
Theoretical value 0.3900
Implied Volatility 29.45 %
Total Loss Probability 81.38 %
Intrinsic value 0.000000
Present value 0.3900
Break even 104.24 €
Theta-0.01x
Vega0.03x
Rho0.03x

Company Profile

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
-
More about the company

Ratings for Centene Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Centene Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
71.59 USD
Average target price
88.57 USD
Spread / Average Target
+23.72%
Consensus